Cargando…

Association of postoperative atrial fibrillation with higher dosing ratios of protamine-to-heparin

Background: Postoperative atrial fibrillation (POAF) is defined as new-onset AF in the immediate postoperative period. The relatively high incidence of POAF after cardiac surgery is well described, but pathophysiological mechanisms underlying the initiation, maintenance, and progression of POAF may...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamada, Yasuharu, Iemura, Junzo, Kambara, Atushi, Tateishi, Noboru, Kozaki, Yuji, Yamada, Masako, Maruyama, Junko, Azuma, Eiichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: EDP Sciences 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071503/
https://www.ncbi.nlm.nih.gov/pubmed/37034101
http://dx.doi.org/10.1051/ject/2023003
_version_ 1785019216812834816
author Yamada, Yasuharu
Iemura, Junzo
Kambara, Atushi
Tateishi, Noboru
Kozaki, Yuji
Yamada, Masako
Maruyama, Junko
Azuma, Eiichi
author_facet Yamada, Yasuharu
Iemura, Junzo
Kambara, Atushi
Tateishi, Noboru
Kozaki, Yuji
Yamada, Masako
Maruyama, Junko
Azuma, Eiichi
author_sort Yamada, Yasuharu
collection PubMed
description Background: Postoperative atrial fibrillation (POAF) is defined as new-onset AF in the immediate postoperative period. The relatively high incidence of POAF after cardiac surgery is well described, but pathophysiological mechanisms underlying the initiation, maintenance, and progression of POAF may be multifactorial and have not yet been comprehensively characterized. One of the mechanisms includes altered Ca(2+) kinetics. Accumulating evidence has suggested that altered atrial cytosolic calcium handling contributes to the development of POAF, protamine reversibly modulates the calcium release channel/ryanodine receptor 2 (RyR2) and voltage-dependent cardiac RyR2. However, it is currently unknown whether such abnormalities contribute to the arrhythmogenic substrate predisposing patients to the development of POAF. Methods: We have retrospectively analyzed 147 patients who underwent cardiac surgery with cardiopulmonary bypass support. Of these, 40 patients were excluded from the analysis because of pre-existing AF. All patients received heparin followed by protamine at different dosing ratios of protamine-to-heparin, depending on the periods studied. Results: The dosing ratio of protamine-to-heparin = 1.0 was compared with higher dosing ratios of protamine-to-heparin >1.0 up to 1.7. POAF developed in 15 patients (15/107 = 14%), of these, 5 out of 57 patients (33.3%) in the dosing ratio of protamine-to-heparin = 1.0 and 10 out of 35 patients (66.7%) in the higher dosing ratios of protamine-to-heparin. Statistical significance was observed in patients with higher dosing ratios of protamine-to-heparin, compared with the dosing ratio of protamine-to-heparin = 1.0 (odds ratio = 3.890, 95% CI = 1.130–13.300, p-value = 0.031). When types of diseases were analyzed in terms of higher dosing ratios of protamine-to-heparin, only valvular disorders were significantly associated with POAF (p = 0.04). Conclusions: Protamine is clinically utilized to reverse heparin overdose and has been shown to display immunological and inflammatory alterations. However, its association with POAF has not been reported. Our results provide evidence that higher dosing ratios of protamine-to-heparin may increase the incidence of POAF.
format Online
Article
Text
id pubmed-10071503
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher EDP Sciences
record_format MEDLINE/PubMed
spelling pubmed-100715032023-04-06 Association of postoperative atrial fibrillation with higher dosing ratios of protamine-to-heparin Yamada, Yasuharu Iemura, Junzo Kambara, Atushi Tateishi, Noboru Kozaki, Yuji Yamada, Masako Maruyama, Junko Azuma, Eiichi J Extra Corpor Technol Original Article Background: Postoperative atrial fibrillation (POAF) is defined as new-onset AF in the immediate postoperative period. The relatively high incidence of POAF after cardiac surgery is well described, but pathophysiological mechanisms underlying the initiation, maintenance, and progression of POAF may be multifactorial and have not yet been comprehensively characterized. One of the mechanisms includes altered Ca(2+) kinetics. Accumulating evidence has suggested that altered atrial cytosolic calcium handling contributes to the development of POAF, protamine reversibly modulates the calcium release channel/ryanodine receptor 2 (RyR2) and voltage-dependent cardiac RyR2. However, it is currently unknown whether such abnormalities contribute to the arrhythmogenic substrate predisposing patients to the development of POAF. Methods: We have retrospectively analyzed 147 patients who underwent cardiac surgery with cardiopulmonary bypass support. Of these, 40 patients were excluded from the analysis because of pre-existing AF. All patients received heparin followed by protamine at different dosing ratios of protamine-to-heparin, depending on the periods studied. Results: The dosing ratio of protamine-to-heparin = 1.0 was compared with higher dosing ratios of protamine-to-heparin >1.0 up to 1.7. POAF developed in 15 patients (15/107 = 14%), of these, 5 out of 57 patients (33.3%) in the dosing ratio of protamine-to-heparin = 1.0 and 10 out of 35 patients (66.7%) in the higher dosing ratios of protamine-to-heparin. Statistical significance was observed in patients with higher dosing ratios of protamine-to-heparin, compared with the dosing ratio of protamine-to-heparin = 1.0 (odds ratio = 3.890, 95% CI = 1.130–13.300, p-value = 0.031). When types of diseases were analyzed in terms of higher dosing ratios of protamine-to-heparin, only valvular disorders were significantly associated with POAF (p = 0.04). Conclusions: Protamine is clinically utilized to reverse heparin overdose and has been shown to display immunological and inflammatory alterations. However, its association with POAF has not been reported. Our results provide evidence that higher dosing ratios of protamine-to-heparin may increase the incidence of POAF. EDP Sciences 2023-03-24 /pmc/articles/PMC10071503/ /pubmed/37034101 http://dx.doi.org/10.1051/ject/2023003 Text en © The Author(s), published by EDP Sciences, 2023 https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Yamada, Yasuharu
Iemura, Junzo
Kambara, Atushi
Tateishi, Noboru
Kozaki, Yuji
Yamada, Masako
Maruyama, Junko
Azuma, Eiichi
Association of postoperative atrial fibrillation with higher dosing ratios of protamine-to-heparin
title Association of postoperative atrial fibrillation with higher dosing ratios of protamine-to-heparin
title_full Association of postoperative atrial fibrillation with higher dosing ratios of protamine-to-heparin
title_fullStr Association of postoperative atrial fibrillation with higher dosing ratios of protamine-to-heparin
title_full_unstemmed Association of postoperative atrial fibrillation with higher dosing ratios of protamine-to-heparin
title_short Association of postoperative atrial fibrillation with higher dosing ratios of protamine-to-heparin
title_sort association of postoperative atrial fibrillation with higher dosing ratios of protamine-to-heparin
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071503/
https://www.ncbi.nlm.nih.gov/pubmed/37034101
http://dx.doi.org/10.1051/ject/2023003
work_keys_str_mv AT yamadayasuharu associationofpostoperativeatrialfibrillationwithhigherdosingratiosofprotaminetoheparin
AT iemurajunzo associationofpostoperativeatrialfibrillationwithhigherdosingratiosofprotaminetoheparin
AT kambaraatushi associationofpostoperativeatrialfibrillationwithhigherdosingratiosofprotaminetoheparin
AT tateishinoboru associationofpostoperativeatrialfibrillationwithhigherdosingratiosofprotaminetoheparin
AT kozakiyuji associationofpostoperativeatrialfibrillationwithhigherdosingratiosofprotaminetoheparin
AT yamadamasako associationofpostoperativeatrialfibrillationwithhigherdosingratiosofprotaminetoheparin
AT maruyamajunko associationofpostoperativeatrialfibrillationwithhigherdosingratiosofprotaminetoheparin
AT azumaeiichi associationofpostoperativeatrialfibrillationwithhigherdosingratiosofprotaminetoheparin